Promoting the Health of People with Clotting Disorders

Post Date

April 8th 2009

Application Due Date

June 8th 2009

Funding Opportunity Number

CDC-RFA-DD09-904

CFDA Number(s)

93.184

Funding Instrument Type(s)

Cooperative Agreement

Funding Activity Categories

Health

Number of Awards

5

Eligibility Categories

Other

Eligible applicants that can apply for this funding opportunity are listed below: • Nonprofit with 501C3 IRS status (other than institution of higher education) • Nonprofit without 501C3 IRS status (other than institution of higher education) • For-profit organizations (other than small business) • Small, minority, and women-owned businesses • Universities • Colleges • Research institutions • Hospitals • Community-based organizations • Faith-based organizations • Federally recognized or state-recognized American Indian/Alaska Native tribal governments • American Indian/Alaska native tribally designated organizations • Alaska Native health corporations • Urban Indian health organizations • Tribal epidemiology centers • State and local governments or their Bona Fide Agents (this includes the District of Columbia, the Commonwealth of Puerto Rico, the Virgin Islands, the Commonwealth of the Northern Marianna Islands, American Samoa, Guam, the Federated States of Micronesia, the Republic of the Marshall Islands, and the Republic of Palau) • Political subdivisions of States (in consultation with States) A Bona Fide Agent is an agency/organization identified by the state as eligible to submit an application under the state eligibility in lieu of a state application. If applying as a bona fide agent of a state or local government, a letter from the state or local government as documentation of the status is required. Attach with “Other Attachment Forms” when submitting via www.grants.gov.

Funding

• Estimated Total Funding:

  $600000

• Award Range:

  $100000 - $600000

Grant Description

The purpose of this program is to provide support through CDC cooperative agreements for non-research activities for people affected by clotting that provide access to public health programs that provide accurate and credible health information. These activities should include implementing effective health promotion and wellness programs, or provide training for health care professionals on the early recognition of VTE or management strategies to prevent complications of VTE. The goal of this program is to increase knowledge and awareness, or influence perceptions, beliefs, and attitudes of people who have been affected by clotting (i.e., people who have either experienced or are at increased risk for VTE), or health care professionals about health behaviors to prevent or mitigate secondary conditions associated with clotting.

Contact Information

• Agency

  Department of Health and Human Services

• Office:

  Centers for Disease Control and Prevention

• Agency Contact:

  CDC Procurement and Grants Office
  Technical Information Management Section
  Phone 770-488-2700

• Agency Mailing Address:

  PGO Technical Information Managemen

• Agency Email Address:

  PGOTIM@cdc.gov